T-cell lymphoma

What is in the future for T-cell lymphoma?

Recently, PharmaMar announced the start of a phase 2 clinical trial to evaluate the efficacy of plitidepsin, a potential treatment option for adult patients with relapsed and refractory angioimmunoblastic T-cell lymphoma (AITL). In this VJHemOnc ... Read more

B-Cell Vs T-Cell Lymphomas

Non-Hodgkin lymphomas are the most common and there are about 61 known types of the disease. Unlike Hodgkin lymphoma, Non-Hodgkin lymphoma does not involve Reed-Sternberg cells. It is difficult ... Read more